Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

Por Oza, Amit M., Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta
Publicado no Int J Gynecol Cancer (2017)

The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy

Por Gámez-Pozo, Angelo, Pérez Carrión, Ramón M., Manso, Luis, Crespo, Carmen, Mendiola, Cesar, López-Vacas, Rocío, Berges-Soria, Julia, López, Isabel Álvarez, Margeli, Mireia, Calero, Juan L. Bayo, Farre, Xavier González, Santaballa, Ana, Ciruelos, Eva M., Afonso, Ruth, Lao, Juan, Catalán, Gustavo, Gallego, José V. Álvarez, López, José Miramón, Bofill, Francisco J. Salvador, Borrego, Manuel Ruiz, Espinosa, Enrique, Vara, Juan A. Fresno, Zamora, Pilar
Publicado em 2014